Wikisage, the free encyclopedia of the second generation, is digital heritage
Zimeldine: Difference between revisions
Jump to navigation
Jump to search
(Created page with "While zilmelidine had a very favorable safety profile, within a year and a half of its introduction, rare case reports of Guillain–Barré syndrome emerged that appeared to b...") |
(No difference)
|
Revision as of 14:11, 21 March 2019
While zilmelidine had a very favorable safety profile, within a year and a half of its introduction, rare case reports of Guillain–Barré syndrome emerged that appeared to be caused by the drug, prompting its manufacturer to withdraw it from the market
